A$0.485 0.0 3.2%
Last Trade - 5:10am
| Market Cap | £32.7m |
| Enterprise Value | £30.6m |
| Revenue | £16.8m |
| Position in Universe | 814th / 1832 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Cogstate Limited is a cognitive science company delivering software and services. The Company's segments include cognitive testing in Clinical Trials; the precision recruitment market, the healthcare market, the sport market and administration. In the clinical trials market, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the precision recruitment market, the technology is used as an online screening tool as part of the process of recruiting subjects in clinical trials. In the healthcare market, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. In the sport market, the technology and associated services are used to provide concussion management tools in sport.
| Last Annual | June 30th, 2019 |
| Last Interim | June 30th, 2019 |
| Incorporated | December 17, 1999 |
| Public Since | February 13, 2004 |
| No. of Shareholders: | 1,465 |
| No. of Employees: | 61 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 135,165,748 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | L 2 255 Bourke St, MELBOURNE, 3000, Australia |
| Web | https://cogstate.com/ |
| Phone | +61 3 96641300 |
| Contact | Rebecca Wilson (IR Contact Officer) |
| Auditors | Pitcher Partners |
